Board of Directors

Oppel Greeff, MD
Vice Chairman, Quintiles and Chairman of the Board

Upon joining Quintiles, Dr. Greef served as Medical Director for Quintiles South Africa until January 1999, when he was appointed President of Quintiles Transnational's Africa, India and Australia regions. Latin America was added to his portfolio in 2001. In 2002, Dr. Greeff was appointed Chief Executive Officer of Quintiles' global Early Development and Laboratory Services and President, Global Product Development Services, while retaining his geographic responsibilities.

Paula Brown Stafford
President, Clinical Development, Quintiles

Paula Brown Stafford joined Quintiles in 1985 as a Biostatistician. She is currently Executive Vice President of Integrated Clinical Services for Quintiles. Her responsibilities comprise a number of global business units generating data from clinical trials, including central laboratories, Phase I research groups, cardiac safety, data management and analysis, and the Center for Statistics. 

Ms. Stafford is a member of the Board of Directors of CDISC (Clinical Data Interchange Standards Consortium), the Foundation Board of the School of Public Health at UNC Chapel Hill, the Industry Advisory Board to the BioPharma Management Program at North Carolina State University, and UNC-Chapel Hill School of Medicine CTSA External Advisory Board. 

Patrick M. Durbin
President, Fisher BioPharma Services

Patrick Durbin is President, BioPharma Services, a specialty division of Thermo Fisher Scientific. Patrick joined Thermo Fisher Scientific as General Manager, N. America for Fisher Clinical Services (FCS) in 2006 and was responsible for a suite of high-growth service lines that support the manufacturing, packaging and distribution of drugs, biologics and materials used in clinical trials. Patrick was promoted in 2008 to lead the Fisher Clinical Services business globally. Prior to joining FCS, Patrick had a sixteen year career with Covance (NYSE: CVD), formerly a division of Corning, Inc., where he held a variety of global senior management positions. Patrick holds a Bachelor’s degree in Biology and an M.B.A. in Pharmaceutical Marketing. He has completed the General Management program at Columbia University and the leadership development programs at both Thermo Fisher and Covance.

Ferzaan N. Engineer, Ph.D.
Chief Executive Officer, Quintiles Research

Ferzaan N Engineer, Ph.D., is CEO Quintiles Research (India) Private Limited and Chairman of Quintiles Data Processing Centre (India) Private Limited. He is a member of the Asia-Pacific Management Board of Quintiles responsible for managing the Asia-Pacific geographies. Ferzaan has contributed to establishing and growing the Quintiles organisation in India which currently employs over 1300 people at four locations: Ahmedabad, Bangalore, Mumbai and Delhi. After obtaining his B.Pharm. in 1985 from the LM College of Pharmacy in Ahmedabad, Dr. Engineer completed his Ph.D. in Pharmaceutical Sciences in 1990, from the College of Pharmacy at the University of South Carolina, USA. He has attended management training programs at the Kenan-Flagler Business School (USA) and IIMA (India).

Matthew P. Sudduth
Vice President Finance, Fisher BioPharma Services

Matthew Sudduth is Vice President Finance for the BioPharma Services Division of Thermo Fisher Scientific. Matt joined Thermo Fisher Scientific in 2006 and held various finance leadership roles in the Specialty Diagnostics Group before joining the BioPharma Services Division in 2010. In his current role he is responsible for all financial aspects and strategic planning activities across the division’s suite of high-growth service lines that support the manufacturing, packaging and distribution of drugs, biologics and materials used in clinical trials. Prior to joining Thermo Fisher Scientific, Matt was the Director of Corporate Finance at GenTek Inc. a diversified chemical, telecommunications and specialty automobile supply company. Prior to Gentek, Matt was a Merchant Banking Associate with Latona Associates and an Equity Analyst with Mark Asset Management. Matt holds a Bachelor’s degree in Philosophy from Bates College and an M.B.A. from Columbia University.

John Sabo
Vice President and General Counsel, Customer Channels Group, 
Thermo Fisher Scientific

John Sabo currently serves as Vice President and General Counsel of the Customer Channels Group of Thermo Fisher Scientific.  In this role, John has responsibility for the Legal, Regulatory and Quality functions of the $4B global channel business branded as "Fisher Scientific".  Prior to joining Thermo Fisher Scientific, John served in similar roles for several multinational companies, including Ariba, Marconi Communications and Black Box Corporation.  John began his legal career with the law firm of Meyer, Unkovic & Scott LLP in Pittsburgh, where he was a member of the firm’s Business Transactions and Planning Group.  His practice focused on acquisitions and divestitures, private capital formation, joint ventures, contracts and licensing.

John received his Bachelor’s degree in Economics from Carnegie-Mellon University and his Juris Doctorate from Duquesne University.